Continuous Glucose Error-Grid Analysis for Sensor Accuracy Evaluation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional methods for evaluating the accuracy of continuous glucose monitoring sensors fail to account for temporal characteristics of blood glucose fluctuations, leading to misleading results when assessing clinical implications of errors.

Innovation Solution

The Continuous Glucose Error-Grid Analysis (CG-EGA) method combines Point Error-Grid Analysis and Rate Error-Grid Analysis to evaluate both the accuracy of blood glucose values and the direction and rate of fluctuations, providing a comprehensive assessment of sensor precision that preserves clinical assumptions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional accuracy measures (statistical correlation or regression) are used to evaluate continuous glucose sensors, then the evaluation is simple and straightforward, but the measures fail to capture temporal characteristics of blood glucose fluctuations leading to misleading results

Engineering Contradiction:
Improveaccuracy evaluationVSAvoidtemporal characteristics
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The evaluation method segments the continuous glucose data into discrete time points for point-by-point accuracy assessment using Error Grid Analysis, while separately evaluating temporal characteristics through rate of change and direction of fluctuation metrics. This segmentation allows comprehensive evaluation without losing temporal information.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention adds temporal dimension to the traditional static accuracy evaluation by incorporating time-series analysis metrics such as rate of change, direction of fluctuation, and temporal patterns. This transforms the evaluation from a single-dimension (point accuracy) to multi-dimensional (including temporal dynamics).

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Ease of operation

If static accuracy measures are applied to continuous glucose sensors, then the evaluation process is simple, but it is inappropriate for capturing the dynamics of blood glucose fluctuations

Engineering Contradiction:
Improveevaluation processVSAvoidclinical implications
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The evaluation system transitions from static point accuracy assessment to dynamic evaluation by continuously monitoring and analyzing the rate of change, direction, and temporal patterns of glucose fluctuations. This dynamic approach reliably captures clinical implications while maintaining systematic evaluation procedures.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The invention introduces intermediate metrics such as rate of change, direction of fluctuation, and temporal pattern analysis as mediators between the raw continuous glucose data and the final accuracy assessment. These intermediaries bridge the gap between simple evaluation and comprehensive clinical relevance.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If traditional Error-Grid_analysis is used for continuous glucose sensors, then the point accuracy is evaluated, but the temporal structure and dynamics of the data are ignored

Engineering Contradiction:
Improvepoint accuracyVSAvoidtemporal structure
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The invention merges traditional Error Grid Analysis (for point accuracy) with temporal analysis metrics (rate of change, direction of fluctuation, time patterns) into a unified comprehensive evaluation framework. This combination preserves point accuracy assessment while simultaneously capturing temporal structure without losing either dimension of information.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS7815569B2Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices
Publication Date: 2010.10.19 UNIV OF VIRGINIA PATENT FOUND
  • US7815569B2 patent drawing
  • US7815569B2 patent drawing
  • US7815569B2 patent drawing

AI summary

Continuous Glucose Error-Grid Analysis (CG-EGA) method, system or computer program product designed for evaluation of continuous glucose sensors providing frequent BG readings. The CG-EGA estimates the precision of such sensors/devices in terms of both BG values and temporal characteristics of BG fluctuation. The CG-EPA may account for, among other things, specifics of process characterization (location, speed and direction), and for biological limitations of the observed processes (time lags associated with interstitial sensors).